Myomectomy Market Size

Myomectomy Market Size

Myomectomy Market size was valued at USD 681 million in 2022 and is estimated to account for USD 1.6 billion by 2032. Myomectomy is a surgical procedure aimed at removing noncancerous growths known as uterine fibroids from the muscular wall of the uterus. The primary objective of myomectomy is to surgically eliminate the fibroids while preserving the uterus, making it an option for women wishing to retain their fertility or avoid a hysterectomy.

To get key market trends

  Download Free Sample

Additionally, this procedure can be performed using various methods, including open surgery, laparoscopy, and robotic-assisted surgery. Furthermore, the market is driven by a growing prevalence of uterine fibroids, increasing adoption of advanced surgical technology, rising demand for minimally invasive procedures, and improved healthcare infrastructure, especially in developing countries. These factors collectively contribute to the market expansion.
 

The growing prevalence of uterine fibroids, noncancerous growths in the uterine muscle tissue, is a significant health concern among women, especially those of childbearing age. For instance, according to the Illinois Department of Public Health around 77% women of childbearing age may have uterine fibroids. Additionally, according to the Society for Women’s Health Research report, in the U.S. approximately 26 million women ages 15-50 have uterine fibroids. Therefore, as more women are diagnosed with uterine fibroids, there is an increasing demand for effective treatment options to address the associated symptoms. Furthermore, minimally invasive techniques such as laparoscopy and robotic-assisted surgery are gaining popularity in myomectomy. They involve smaller incisions, reduced blood loss, shorter hospital stays, and faster recovery times compared to open surgery. Thus, patients increasingly prefer myomectomy for less post-operative pain and smaller scars.